“Chemsex,” the use of stimulants and other drugs combined with high-risk sexual behavior, has reached crisis proportions among older people living with HIV/AIDS and Black Gay Men. In this panel discussion, presenters will explore this phenomenon in both clinical and deeply personal terms.
UCHAPS knows that PrEP is a valuable tool that women can use to take control of their sexual health and is committed to raising awareness among women about PrEP. Join UCHAPS for a discussion on the unique issues surrounding women and PrEP and representation of women in PrEP research.
Join UCHAPS and NASTAD to discuss the benefits of e-learning by leveraging online technical assistance platforms as a vehicle for capacity building assistance. As health departments begin to seek cost-effective methods to build capacity, modern systems that optimize efficacy without sacrificing quality require further exploration.
15 years ago, UCHAPS first articulated its urban health agenda. It defined the HIV prevention challenges that must be faced by elected and public officials, health and social service providers, individuals, families and communities to stop the continued spread of new HIV infections in urban America.
Curious about how to get more youth involved in HIV prevention work? For health departments and community organizations interested in engaging youth in HIV prevention activities, join UCHAPS for a webinar as UCHAPS member jurisdictions share their work.
People living with HIV, their partners, healthcare providers and criminal justice system should have accurate information about viral suppression of HIV. One of the benefits of viral suppression includes being incapable of transmitting the virus. Join this UCHAPS to learn more about U=U.
In this webinar, we discuss creating best practices and share strategies from UCHAPS member jurisdictions to address meth and opioid use among black gay men.
This webinar aims to create the dialogue about the impact of crystal meth and opioids on black gay men. Already bearing the burden of HIV, meth and opioid use can be devastating to a community already struggling to find resources. By bringing awareness to this subject, we can begin to shift attention to meet needs of an overlooked community.
Join UCHAPS and NASTAD for a webinar on methamphetamine use and methamphethamine-specific harm reduction practices that can be adopted within health departments, substance use and syringe service programs (SSPs).
Injection drug use presents an enormous HIV prevention challenge throughout the United States. Syringe access programs have proven to be an effective intervention in preventing disease and other health burdens by providing sterile syringes, sterile injection equipment, and education to people who inject drugs, steroids, and hormones.
Transgender populations suffer from a disproportionately high rate of HIV. HIV prevention programs are often a gateway for transgender persons into social service and health care systems so it is critical that these are incorporated into the larger health and wellness initiatives
NCHHSTP AtlasPlus gives you the power to access data reported to CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Use HIV, viral hepatitis, STD, and TB data to create maps, charts, and detailed reports, and analyze trends and patterns.
amfAR's Opioid & Health Indicators database is a window into the opioid epidemic unfolding in every American's backyard—it provides local to national statistics using reliable data sources on new HIV and hepatitis C infections, opioid use and overdose death rates, and the availability of services like drug treatment programs and syringe exchange services.
This resource center was supported by the Cooperative Agreement, #NU65PS004588 funded by the Centers of Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers of Disease Control and Prevention or the Department of Health and Human Services.